So far, over 30,000 COVID-19 patients in Israel have been treated with the anti-viral Paxlovid drug.
Patients who received the fourth dose were 76% less likely to die compared to those who received just the third dose.
Essence Group, is a leading technology company, which develops cloud-based, end-to-end security and healthcare solutions that protect people while they’re at work and at home.
The pilot project is a collaboration between Essence SmartCare, Clalit Health Services and Sharan Medical Care and can reduce hospital occupancy during the COVID-19 pandemic and beyond.
Two Technion PhD students have created animated explanatory videos to educate patients on genetic counseling, giving patients access to the knowledge needed to make informed decisions.
Doctors say that even if the vaccine does have an impact on menstruation, it is short-term and the vaccine does not affect fertility.
Regeneron was authorized in November for emergency use by the US Food and Drug Administration (FDA).
Some 73% of organ transplant patients who received a third coronavirus vaccine developed antibodies compared to only 35% after the second vaccine, according to new research.
Thanks to the Abraham Accords, Israeli and Emirati insurance companies are working together to build a healthier Middle East.